Adocia
About
History
Management
Board of directors
Advisory board
Products and platforms
Pipeline
Technology Platforms
Careers
The « Adocians »
HR policy
Work environment
Join us
Partnering
Investors
Media
Contact
Contact us
Map and accessibility
Investors
Press releases
Regulated information
Stock information
Corporate governance
General meeting
Media
Press releases
Media
EN
FR
ADOCIA Presents Clinical Results on M1Pram at the 14th International Conference on ATTD 2021
Previous article
ADOCIA reinforces its board of directors with the appointment of three new independent members.
Next article
ADO09, a co-formulation of pramlintide and insulin A21G improves postprandial glucose (PPG) versus insulin Aspart in type 1 diabetes, Dr. Grégory Meiffren, June 2, 2021, ATTD, Virtual event.
